INNOVATION ACTA SRL
Via Delle Province 1 – Siena – 53100
VAT: IT13201341008
nan
Complicit EU Projects
Within the Horizon 2020 (2014-2020) framework, INNOVATION ACTA SRL has received € 738,600.0 for its participation in a total of 3 project(s) with a total cost of € 15,643,346.
| Start (YYYYMMDD) | Project ID | Project Name | Themes | End (YYYYMMDD) | Role | EC Contribution | Total Cost | IL Participation | Total Participation | CORDIS Link |
|---|---|---|---|---|---|---|---|---|---|---|
| 2019-03-01 | 820292 | RESTORE | pharmaceutical drugs · oncology | 2020-07-31 | participant | € 587,500.0 | € 1,000,000 | 1 | 11 | CORDIS ↪ |
| 2018-01-01 | 779293 | HIPGEN | public health · surgery · pharmaceutical drugs · immunology · cells technologies | 2022-09-30 | participant | € 83,225.0 | € 7,437,127 | 2 | 17 | CORDIS ↪ |
| 2017-01-01 | 733006 | PACE | mortality · pharmaceutical drugs · diabetes · retinopathy · cells technologies | 2021-12-31 | participant | € 67,875.0 | € 7,206,218 | 1 | 12 | CORDIS ↪ |
Within the Horizon Europe (2021-2027) framework, INNOVATION ACTA SRL has received € 675,536.0 for its participation in a total of 2 project(s) with a total cost of € 17,844,578.
| Start (YYYYMMDD) | Project ID | Project Name | Themes | End (YYYYMMDD) | Role | EC Contribution | Total Cost | IL Participation | Total Participation | CORDIS Link |
|---|---|---|---|---|---|---|---|---|---|---|
| 2023-01-01 | 101095635 | PROTO | rheumatology · cells technologies · homeostasis | 2027-12-31 | participant | € 303,363.5 | € 7,447,875 | 1 | 10 | CORDIS ↪ |
| 2023-12-01 | 101136622 | THRIVE | artificial intelligence · liver cancer · mortality · surgical procedures · microbiology | 2028-11-30 | participant | € 372,173.75 | € 10,396,703 | 1 | 13 | CORDIS ↪ |
INNOVATION ACTA SRL did not participate in FP7 (2007-2013).